Immunoglobulin disorders at diagnosis and course of B-chronic lymphocytic leukemia (B-CLL) patients

被引：0
|
作者：
Vassilakopoulos, TP [1 ]
Angelopoulou, MK [1 ]
Gribabis, DA [1 ]
Siakantaris, MP [1 ]
Boussiotis, VA [1 ]
Pangalis, GA [1 ]
机构：
[1] NATL & KAPODISTRIAN UNIV ATHENS,DEPT INTERNAL MED 1,LAIKON GEN HOSP,ATHENS,GREECE
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 1996年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：457 / 457
页数：1
相关论文
共 50 条
  • [21] CD38 expression identifies two distinct prognostic subsets in B-chronic lymphocytic leukemia (B-CLL).
    Del Poeta, G
    Maurillo, L
    Venditti, A
    Buccisano, F
    Del Moro, B
    Suppo, G
    Epiceno, AM
    Del Principe, MI
    Masi, M
    Amadori, S
    BLOOD, 2000, 96 (11) : 366A - 367A
  • [22] UCN-01 chemosensitizes human B-chronic lymphocytic leukemia (B-CLL) cells to the effects of fludarabine.
    Willis, C
    Byrd, JC
    Shinn, C
    Flinn, IW
    Grever, MR
    BLOOD, 1999, 94 (10) : 127A - 127A
  • [23] Derivation of expanded killer cells from patients with B-chronic lymphocytic leukemia (B-CLL): A potential source for cellular immunotherapy.
    Guven, H
    Gilljam, M
    Chambers, BJ
    Ljunggren, HG
    Christensson, B
    Kimby, E
    Dilber, MS
    BLOOD, 2002, 100 (11) : 595A - 595A
  • [24] Novel bax mutations in chronic lymphocytic leukemia (B-CLL)
    Moshynska, O
    Sheridan, DP
    Saxena, A
    FASEB JOURNAL, 2001, 15 (04): : A589 - A589
  • [25] VH analysis in familial chronic lymphocytic leukemia (B-CLL).
    Siakantaris, MP
    Kontopidou, FN
    Kyrtsonis, MC
    Vassilakopoulos, TP
    Kokoris, SI
    Dimopoulou, MN
    Dimitriadou, EM
    Angelopoulou, MK
    Pangalis, GA
    BLOOD, 2003, 102 (11) : 670A - 670A
  • [26] Reduced intensity conditioning in patients with B-chronic lymphocytic leukaemia (B-CLL):: results of a prospective multicentre trial
    Caballero, D
    Martino, R
    Mateos, M
    León, A
    Urbano, A
    Sanz, G
    Sarrá, J
    Simón, JP
    Valcarcel, D
    Sureda, A
    Sierra, J
    San Miguel, J
    BONE MARROW TRANSPLANTATION, 2004, 33 : S110 - S110
  • [27] Aberrant expression of TRAIL in B chronic lymphocytic leukemia (B-CLL) cells
    Secchiero, P
    Tiribelli, M
    Barbarotto, E
    Celeghin, C
    Michelutti, A
    Masolin, P
    Fanin, R
    Zauli, G
    JOURNAL OF CELLULAR PHYSIOLOGY, 2005, 205 (02) : 246 - 252
  • [28] GUIDELINES FOR DIAGNOSIS AND TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA. KROHEM B-CLL 2017
    Jaksic, Branimir
    Pejsa, Vlatko
    Ostojic-Kolonic, Slobodanka
    Kardum-Skelin, Ika
    Basic-Kinda, Sandra
    Coha, Bozena
    Gveric-Krecak, Velka
    Vrhovac, Radovan
    Jaksic, Ozren
    Aurer, Igor
    Sincic-Petricevic, Jasminka
    Nacinovic-Duletic, Antica
    Nemet, Damir
    ACTA CLINICA CROATICA, 2018, 57 (01) : 190 - 215
  • [29] Tonsillar involvement in Rai O B-chronic lymphocytic leukemia (B-CLL) patients. A histologic, immunophenotypic and adhesion molecule study.
    Angelopoulou, MK
    Siakantaris, MM
    Kourtis, I
    Panayiotidis, P
    Kontopidou, FN
    Kittas, C
    Pangalis, GA
    BLOOD, 1995, 86 (10) : 3298 - 3298
  • [30] Inhibition of spontaneous apoptotic cell death of B-chronic lymphocytic leukemia (B-CLL) cells by interleukin-12 in vitro
    Duensing, S
    Schuhknecht, S
    Franzke, A
    Buer, J
    ProbstKepper, M
    Hoffmann, R
    Ganser, A
    Atzpodien, J
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1200 - 1200
12345